145 related articles for article (PubMed ID: 3511376)
1. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
Nyrén O; Adami HO; Bates S; Bergström R; Gustavsson S; Lööf L; Nyberg A
N Engl J Med; 1986 Feb; 314(6):339-43. PubMed ID: 3511376
[TBL] [Abstract][Full Text] [Related]
2. Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trial.
Isenberg JI; Peterson WL; Elashoff JD; Sandersfeld MA; Reedy TJ; Ippoliti AF; Van Deventer GM; Frankl H; Longstreth GF; Anderson DS
N Engl J Med; 1983 Jun; 308(22):1319-24. PubMed ID: 6341844
[TBL] [Abstract][Full Text] [Related]
3. Low-dose antacids versus 400 mg cimetidine twice daily for reflux oesophagitis. A comparative, placebo-controlled, multicentre study.
Farup PG; Weberg R; Berstad A; Wetterhus S; Dahlberg O; Dybdahl J; Fyllingen G; Kannelønning KS; Lange OJ
Scand J Gastroenterol; 1990 Mar; 25(3):315-20. PubMed ID: 2181623
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine in the treatment of non-ulcer dyspepsia. A placebo-controlled study in the Federal Republic of Germany.
Müller P; Hotz J; Franz E; Simon B
Arzneimittelforschung; 1994 Oct; 44(10):1130-2. PubMed ID: 7818586
[TBL] [Abstract][Full Text] [Related]
5. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Carvalhinhos A; Fidalgo P; Freire A; Matos L
Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
[TBL] [Abstract][Full Text] [Related]
6. Cimetidine, antacid, and hospitalization in the treatment of benign gastric ulcer: a multicenter double blind study.
Englert E; Freston JW; Graham DY; Finkelstein W; Kruss DM; Priest RJ; Raskin JB; Rhodes JB; Rogers AI; Wenger J; Wilcox LL; Crossley RJ
Gastroenterology; 1978 Feb; 74(2 Pt 2):416-25. PubMed ID: 340332
[TBL] [Abstract][Full Text] [Related]
7. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
[TBL] [Abstract][Full Text] [Related]
8. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
Rappaport BS
N Engl J Med; 1986 Sep; 315(12):763-4. PubMed ID: 3528852
[No Abstract] [Full Text] [Related]
9. Cimetidine and placebo in the treatment of benign gastric ulcer: a multicenter double blind study.
Dyck WP; Belsito A; Fleshler B; Liebermann TR; Dickinson PB; Wood JM
Gastroenterology; 1978 Feb; 74(2 Pt 2):410-5. PubMed ID: 340331
[TBL] [Abstract][Full Text] [Related]
10. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin.
Gotthard R; Bodemar G; Brodin U; Jönsson KA
Scand J Gastroenterol; 1988 Jan; 23(1):7-18. PubMed ID: 3278366
[TBL] [Abstract][Full Text] [Related]
11. Treatment of duodenal ulcer with antacids in combination with trimipramine or cimetidine.
Berstad A; Bjerke K; Carlsen E; Aadland E
Scand J Gastroenterol Suppl; 1980; 58():46-52. PubMed ID: 6988942
[TBL] [Abstract][Full Text] [Related]
12. Long term cimetidine in the management of severe duodenal ulcer dyspepsia.
Gray GR; Smith IS; Mackenzie I; Gillespie G
Gastroenterology; 1978 Feb; 74(2 Pt 2):397-401. PubMed ID: 340329
[TBL] [Abstract][Full Text] [Related]
13. Cimetidine vs placebo: complete gastric ulcer pain relief. Six week controlled double blind study without any antacid therapy.
Collen MJ; Stubrin SE; Hánan MR; Maher JA; Rent M
Acta Gastroenterol Latinoam; 1980; 10(4):291-5. PubMed ID: 7023166
[TBL] [Abstract][Full Text] [Related]
14. Cimetidine versus intensive antacid therapy for duodenal ulcer: a multicenter trial.
Ippoliti AF; Sturdevant RA; Isenberg JI; Binder M; Camacho R; Cano R; Cooney C; Kline MM; Koretz RL; Meyer JH; Samloff IM; Schwabe AD; Strom EA; Valenzuela JE; Wintroub RH
Gastroenterology; 1978 Feb; 74(2 Pt 2):393-5. PubMed ID: 340327
[TBL] [Abstract][Full Text] [Related]
15. The relationship between active peptic ulcer, endoscopic duodenitis and symptomatic state after treatment with cimetidine.
Danielsson A; Ek B; Nyhlin H; Steen L
Ann Clin Res; 1980 Feb; 12(1):4-12. PubMed ID: 6990861
[TBL] [Abstract][Full Text] [Related]
16. Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief?
Parr SN
Curr Med Res Opin; 1989; 11(9):557-66. PubMed ID: 2692970
[TBL] [Abstract][Full Text] [Related]
17. Recurrent ulcer after successful treatment with cimetidine or antacid.
Ippoliti A; Elashoff J; Valenzuela J; Cano R; Frankl H; Samloff M; Koretz R
Gastroenterology; 1983 Oct; 85(4):875-80. PubMed ID: 6350097
[TBL] [Abstract][Full Text] [Related]
18. Once-daily bedtime dosing regimen of cimetidine in the treatment of gastric ulcer.
Frank WO; Young M; Palmer RH; Karlstadt R; Rockhold F; Mounce W
Clin Ther; 1989; 11(5):595-603. PubMed ID: 2680085
[TBL] [Abstract][Full Text] [Related]
19. Additional antacid does not increase the effect of cimetidine in gastric ulcer disease.
Rune SJ; Jensen KG; Wulff HR; Bendtsen F; Lindskov J; Mejer J; Højlund M; Nissen VR; Willumsen L; Agner E
Scand J Gastroenterol; 1984 Jan; 19(1):56-8. PubMed ID: 6369522
[TBL] [Abstract][Full Text] [Related]
20. Cimetidine vs. placebo in prepyloric gastric ulcer therapy. Six week controlled double blind investigation without any antacid therapy.
Collen M; Stubrin S; Hanan M; Maher J; Rent M
Acta Gastroenterol Latinoam; 1980; 10(3):199-202. PubMed ID: 7013403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
